C0041365||DR-70
C0020980||immunoassay
C0041365||tumor marker
C0007131||non-small cell lung cancer
C0242379||Lung cancer
C0242379||lung cancer
C0430022||diagnosed
C0005898||advanced
C0005898||locally advanced stage
C0596473||early diagnosis
C0242379||lung cancer
C0596473||early detection
C0242379||lung cancer
C0040405||low-dose computed tomography
C0041366||tumor biomarkers
C0220825||evaluate
C0041365||DR-70
C0041365||tumor marker
C1511790||detection
C0007131||non-small cell lung cancers
C1550100||serum samples
C0006826||non lung cancer
C0024117||chronic obstructive pulmonary disesase
C0178913||Blood samples
C0679646||participant
C0936012||analyzed
C0041365||DR-70
C2603343||study
C0025266||male
C0043210||female
C0430022||diagnosed
C0149782||squamous cell lung cancer
C0001418||adenocarcinoma
C0007131||non-small cell lung cancer
C0041365||mean serum DR-70
C0242379||lung cancer
C0243095||significantly higher
C0243095||non-cancerous
C2349001||subjects
C0041365||DR-70
C0012634||disease
C0041365||DR-70
C0041365||DR-70
C0041365||marker
C0163275||fibrin degradation products
C0006826||cancers
C0332167||high risk
C0242379||lung cancer